NM_020686.6:c.645C>A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS1
The NM_020686.6(ABAT):c.645C>A(p.Gly215Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000198 in 1,613,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G215G) has been classified as Uncertain significance.
Frequency
Consequence
NM_020686.6 synonymous
Scores
Clinical Significance
Conservation
Publications
- GABA aminotransaminase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Orphanet, G2P
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000204  AC: 31AN: 152142Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.000159  AC: 40AN: 251486 AF XY:  0.000162   show subpopulations 
GnomAD4 exome  AF:  0.000197  AC: 288AN: 1461804Hom.:  0  Cov.: 32 AF XY:  0.000208  AC XY: 151AN XY: 727198 show subpopulations 
Age Distribution
GnomAD4 genome  0.000204  AC: 31AN: 152142Hom.:  0  Cov.: 32 AF XY:  0.000229  AC XY: 17AN XY: 74324 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Gamma-aminobutyric acid transaminase deficiency    Uncertain:1Benign:1 
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at